GOSSAMER BIO, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2016 | — | $-123.0K | $60.0K |
| Dec 2017 | — | $-6.9M | $315.0K |
| Mar 2018 | — | $-29.4M | $79.2M |
| Jun 2018 | — | $-60.8M | $32.3M |
| Sep 2018 | — | $-91.8M | $141.3M |
| Dec 2018 | — | $-120.1M | $105.2M |
| Mar 2019 | — | $480.3M | $170.8M |
| Jun 2019 | $28.3M | $441.4M | $148.5M |
| Sep 2019 | $28.4M | $398.9M | $130.7M |
| Dec 2019 | $28.5M | $352.5M | $135.0M |
| Mar 2020 | $28.5M | $306.5M | $111.4M |
| Jun 2020 | $28.6M | $420.3M | $486.1M |
| Sep 2020 | $28.7M | $372.1M | $462.0M |
| Dec 2020 | $28.7M | $320.7M | $486.1M |
| Mar 2021 | $28.8M | $272.1M | $439.7M |
| Jun 2021 | $28.9M | $220.7M | $342.5M |
| Sep 2021 | $29.0M | $169.8M | $213.5M |
| Dec 2021 | $29.1M | $121.5M | $183.4M |
| Mar 2022 | $29.2M | $30.2M | $138.9M |
| Jun 2022 | $17.6M | $-16.5M | $94.3M |
| Sep 2022 | $14.8M | $56.4M | $153.5M |
| Dec 2022 | $12.0M | $12.1M | $112.0M |
| Mar 2023 | $9.2M | $-28.5M | $65.2M |
| Jun 2023 | $6.4M | $-62.8M | $37.0M |
| Sep 2023 | $3.6M | $104.6M | $82.6M |
| Dec 2023 | $814.0K | $62.8M | $32.1M |
| Mar 2024 | $0 | $26.7M | $38.9M |
| Jun 2024 | $0 | $81.5M | $86.9M |
| Sep 2024 | $0 | $54.1M | $28.5M |
| Dec 2024 | $0 | $29.5M | $46.1M |
| Mar 2025 | — | $-6.3M | $29.0M |
| Jun 2025 | — | $-46.1M | $26.3M |
| Sep 2025 | — | $-82.3M | $8.9M |
| Dec 2025 | — | $-122.8M | $37.7M |
| Mar 2026 | — | $-161.5M | $41.0M |
| Jun 2026 | — | $-94.0M | $41.1M |